Cardiol Therapeutics Inc.

Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.

CRDL | NDAQ

Overview

Corporate Details

ISIN(s):: CA14161Y2006
LEI:
Country:: United States of America
Address:: 602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE
Website:: https://www.cardiolrx.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of novel anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company develops treatments for underserved cardiovascular conditions, with a primary focus on pericarditis, myocarditis, and heart failure. Its lead product candidate, CardiolRx™, is an orally administered cannabidiol solution designed to target the underlying mechanisms of inflammation and fibrosis in cardiac disease. The company's pipeline also includes preclinical candidates. Cardiol Therapeutics collaborates with international research centers and clinical experts to advance its therapeutic programs for patients with debilitating heart conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cardiol Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cardiol Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Cardiol Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
The Global Ltd. Holding company for real estate development, building management, and community-integrated hotels.	Japan	3271
The Lifestyle Group Developed luxury/well-being ventures & provided multimedia systems for franchise network growth.	Italy	TLSG
Theranexus A biopharma developing drugs for rare neurological diseases by targeting non-neuronal cells.	France	ALTHX
THE WHY HOW DO COMPANY, Inc. A corporate regeneration platform for business turnarounds, M&A, and succession solutions.	Japan	3823
Tiziana Life Sciences Ltd Biotech firm developing immunotherapies for neurodegenerative diseases like MS and Alzheimer's.	United States of America	TLSA
TME Pharma N.V. Developing therapies for aggressive cancers by neutralizing the tumor microenvironment.	Germany	ALTME
TOKAI LEASE CO.,LTD. Manufactures and leases temporary buildings and fixtures for the construction sector.	Japan	9761
ToolGen Incorporated A biotech firm licensing genome editing patents for therapeutics and agriculture.	South Korea	199800
Trade Desk, Inc. A self-service platform for ad agencies & brands to manage data-driven digital ad campaigns.	United States of America	TTD
Trainers´ House Oyj Consulting & coaching firm driving growth via leadership, sales & strategy execution.	Finland	TRH1V